Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT
Gain Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 82.24K | n/a | n/a | n/a | 64.8K | n/a | n/a | 55.18K | 140.11K | n/a | 95.1K | 45.01K | 36.34K | 27.34K | 89.17K | 5.27K |
Cost of Revenue | n/a | 20.66K | 21.31K | 21.64K | 20.59K | 20.53K | 23.59K | 20.51K | n/a | n/a | 18.11K | n/a | 18.24K | 8.21K | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -20.66K | -21.31K | -21.64K | -20.59K | -20.53K | -23.59K | -20.51K | -20.24K | n/a | 122K | -19.61K | 76.86K | 36.8K | -1.44M | -2.45M | -1.7M | -1.42M |
Operating Income | -5.09M | -4.37M | -3.33M | -4.46M | -8.18M | -4.38M | -4.41M | -4.89M | -7.73M | -5.23M | -4.56M | -4.75M | -5.18M | -3.29M | -3.21M | -4.64M | -3.51M | -2.47M |
Interest Income | 42.57K | 40.41K | 51.86K | 105.41K | 84.53K | 115.3K | 106.27K | 106K | 129.93K | n/a | n/a | n/a | 59.9K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -5.67M | -4.43M | -3.26M | -4.47M | -8.14M | -3.99M | -4.71M | -4.7M | -7.66M | -5.12M | -4.6M | -4.55M | -5.08M | -3.27M | -3.23M | -4.66M | -3.55M | -2.45M |
Net Income | -5.81M | -4.53M | -3.77M | -4.49M | -8.14M | -4.01M | -4.72M | -4.72M | -7.69M | -5.14M | -4.67M | -4.56M | -5.09M | -3.27M | -3.22M | -4.66M | -3.56M | -2.45M |
Selling & General & Admin | 2.33M | 2.11M | 2.11M | 1.84M | 3.75M | 1.86M | 2.02M | 2.52M | 3.74M | 2.49M | 2.29M | 2.79M | 2.69M | 1.78M | 1.78M | 2.19M | 1.81M | 1.05M |
Research & Development | 2.76M | 2.26M | 1.21M | 2.62M | 4.44M | 2.5M | 2.37M | 2.37M | 3.99M | 2.79M | 2.27M | 1.96M | 2.58M | 1.56M | 1.47M | 2.48M | 1.79M | 1.42M |
Other Expenses | n/a | n/a | -11.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.93K | -11.37K | -7.56K | n/a |
Operating Expenses | 5.09M | 4.37M | 3.31M | 4.46M | 8.18M | 4.36M | 4.38M | 4.89M | 7.73M | 5.28M | 4.56M | 4.75M | 5.27M | 3.33M | 3.25M | 4.66M | 3.6M | 2.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.65K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -12.53K | -14.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.09M | 4.37M | 3.33M | 4.46M | 8.18M | 4.38M | 4.41M | 4.89M | 7.73M | 5.28M | 4.56M | 4.75M | 5.27M | 3.33M | 3.25M | 4.66M | 3.6M | 2.47M |
Income Tax Expense | 141.21K | 100.51K | 504.74K | 10.99K | 1.21K | 19.87K | 14.5K | 21.46K | 26.59K | 16.73K | 78.11K | 4.05K | 9.15K | 1.68K | -8.24K | 5.11K | 3.66K | 3.48K |
Shares Outstanding (Basic) | 30.34M | 28.69M | 27.13M | 26.53M | 19.22M | 17.98M | 16.21M | 12.7M | 12.39M | 11.94M | 11.88M | 11.88M | 11.83M | 11.88M | 10.17M | 11.88M | 11.88M | 11.6M |
Shares Outstanding (Diluted) | 30.34M | 28.69M | 27.13M | 26.53M | 19.22M | 17.98M | 16.21M | 12.7M | 12.39M | 11.94M | 11.88M | 11.88M | 11.88M | 11.88M | 10.17M | 11.88M | 11.88M | 11.6M |
EPS (Basic) | -0.19 | -0.16 | -0.14 | -0.17 | -0.42 | -0.22 | -0.29 | -0.37 | -0.62 | -0.43 | -0.39 | -0.38 | -0.43 | -0.28 | -0.32 | -0.39 | -0.3 | -0.21 |
EPS (Diluted) | -0.19 | -0.16 | -0.14 | -0.17 | -0.42 | -0.22 | -0.29 | -0.37 | -0.62 | -0.43 | -0.39 | -0.38 | -0.43 | -0.28 | -0.32 | -0.39 | -0.3 | -0.21 |
EBITDA | -5.09M | -4.37M | -3.31M | -4.44M | -8.16M | -4.37M | -4.4M | -4.89M | -7.72M | -5.21M | -4.54M | -4.75M | -5.18M | -3.28M | -3.21M | -4.6M | -3.51M | -2.46M |
EBIT | -5.67M | -4.37M | -3.33M | -4.46M | -8.18M | -4.38M | -4.41M | -4.89M | -7.73M | -5.23M | -4.56M | -4.75M | -5.18M | -3.29M | -3.21M | -4.64M | -3.51M | -2.47M |
Depreciation & Amortization | n/a | 20.66K | 21.31K | 21.64K | 20.59K | 20.53K | 23.59K | 20.51K | 20.24K | 19.24K | 18.11K | 19.61K | 18.24K | 8.21K | 5.79K | 54.27K | 2.16K | 3.4K |